IMC Chicago
SRNE

IMC Chicago’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

IMC Chicago’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-140,300
Closed -$652K – 1303
2021
Q4 		$652K Buy
140,300
+12,200
+10% +$75.7K ﹤0.01% 1055
2021
Q3 		$977K Buy
128,100
+10,900
+9% +$92.4K ﹤0.01% 1005
2021
Q2 		$1.14M Sell
117,200
-33,800
-22% -$269K ﹤0.01% 885
2021
Q1 		$1.25M Sell
151,000
-182,700
-55% -$1.93M ﹤0.01% 820
2020
Q4 		$2.28M Sell
333,700
-52,100
-14% -$418K ﹤0.01% 709
2020
Q3 		$4.3M Buy
385,800
+101,000
+35% +$924K 0.01% 444
2020
Q2 		$1.79M Buy
+284,800
New +$1.09M ﹤0.01% 586

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return